Description:
Home Page: www.nrxpharma.com
1201 Orange Street
Wilmington,
DE
19801
United States
Phone:
484 254 6134
Officers
| Name | Title |
|---|---|
| Dr. Jonathan C. Javitt M.D., M.P.H. | Co-Founder, Chief Scientist & Director |
| Mr. Robert Besthof M.I.M. | Head of Operations, Chief Commercial & Patient Officer |
| Mr. Stephen H. Willard Esq. | CEO & Director |
| Prof. Daniel C. Javitt | Co-Founder & Chairman of Scientific Advisory Board |
| Dr. Seth L. Van Voorhees Ph.D. | CFO & Treasurer |
| Suzanne Messere | Investor Relations |
| Dr. Michael Kunz | Gen. Counsel & Corp. Sec. |
| Ms. Molly Cogan | Sr. Director of Global Communications & Gov. Affairs |
| Dr. Philip T. Lavin Ph.D. | Chief Methodologist |
| Dr. Dennis K. McBride Ph.D. | Chief Strategy Officer & Sr. Scientist |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2017-12-01 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |